MACULOPATHY INDUCED BY ANTIMALARIALS IN A COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM COLOMBIA

被引：0
|
作者：
Herrera, Sebastian [1 ]
Camilo Diaz-Coronado, Juan [1 ,3 ]
Hernandez, Deicy [1 ]
Durango, Yecenia [1 ]
Posada, Marcela [2 ]
Mora, Jorge [2 ]
Montoya, Mariana [2 ]
Calle Estrada, Mateo [2 ]
Posada, Cristina [2 ]
Montano, Juanita [2 ]
Calle Estrada, Mateo [2 ]
Camila Soto, Maria [2 ]
Pineda-Tamayo, Ricardo [1 ]
机构：
[1] Grp Informac Clin, Artmed, Medellin, Colombia
[2] Hosp Gen Medellin Luz Castro Gutierrez, Medellin, Colombia
[3] Univ CES, Medellin, Colombia
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
310
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [21] Maculopathy in patient with systemic lupus erythematosus treated with hydroxychloroquine
    Jorge Rodriguez-Hurtado, Francisco
    Antonio Saez-Moreno, Jose
    Manuel Rodriguez-Ferrer, Jose
    [J]. REUMATOLOGIA CLINICA, 2012, 8 (05): : 280 - 283
  • [22] Severe infections in a cohort of patients with systemic lupus erythematosus
    Gonzalez Leon, Rocio
    Castillo Palma, Maria Jesus
    Garcia Hernandez, Francisco Jose
    Sanchez Roman, Julio
    [J]. MEDICINA CLINICA, 2010, 135 (08): : 365 - 367
  • [23] Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions
    Ugarte, Amaia
    Danza, Alvaro
    Ruiz-Irastorza, Guillermo
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (05) : 482 - 489
  • [24] Lupus-related vasculitis in a cohort of systemic lupus erythematosus patients
    Gamal, Sherif M.
    Mohamed, Sally S.
    Tantawy, Marwa
    Siam, Ibrahem
    Soliman, Ahmed
    Niazy, Marwa H.
    [J]. ARCHIVES OF RHEUMATOLOGY, 2021, 36 (04) : 595 - 602
  • [25] Antimalarials may influence the risk of malignancy in systemic lupus erythematosus
    Ruiz-Irastorza, G.
    Ugarte, A.
    Egurbide, M. V.
    Garmendia, M.
    Pijoan, J. I.
    Martinez-Berriotxoa, A.
    Aguirre, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (06) : 815 - 817
  • [26] Systemic lupus erythematosus therapy. Antimalarials is inflammatory diseases
    Yebra-Bango, M
    Tutor-Ureta, P
    [J]. REVISTA CLINICA ESPANOLA, 2004, 204 (11): : 565 - 566
  • [27] Risk of Serious Infection for Patients with Systemic Lupus Erythematosus Starting Glucocorticoids with or without Antimalarials
    Herrinton, Lisa J.
    Liu, Liyan
    Goldfien, Robert
    Michaels, M. Alex
    Tran, Trung N.
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (08) : 1503 - 1509
  • [28] SYSTEMIC LUPUS ERYTHEMATOSUS IN COLOMBIA: A BIBLIOMETRIC ANALYSIS
    Barahona-Correa, J.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S44 - S44
  • [29] DIRECT COSTS OF SYSTEMIC LUPUS ERYTHEMATOSUS IN COLOMBIA
    Castro Villarreal, J. S.
    Beltran-Ostos, A.
    Valencia Arboleda, C. F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1279 - 1280
  • [30] SYSTEMIC LUPUS ERYTHEMATOSUS IN COLOMBIA: A BIBLIOMETRIC ANALYSIS
    Barahona-Correa, J. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 522 - 523
12345